Výsledky vyhledávání - "Ramineh Zoka"

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Autor: Eric I. Felner, Andrea K. Steck, Michael J. Haller, Yichuan Xia, Ramineh Zoka, Joseph A Hedrick, Jocelyn H. Leu, T Ger Study Investigators, Yinglei Li, Mark R. Rigby, Teresa Quattrin, Frank Vercruysse

Publikováno v: N Engl J Med

Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factorIn this phase 2, multicenter, placebo-controlled, double-blind, parallel-g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348dd322d47360729504372f1284867a
https://pubmed.ncbi.nlm.nih.gov/33207099

Zobrazit plný text záznamu

3-LB: Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use and Hypoglycemia in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study

Autor: Eric I. Felner, Joseph A. Hedrick, Karen Xia, Teresa Quattrin, Yinglei Li, Jocelyn H. Leu, Mark R. Rigby, Ramineh Zoka, Michael J. Haller, Frank Vercruysse, Andrea K. Steck

Publikováno v: Diabetes. 69

T1D is an autoimmune disease characterized by progressive loss of pancreatic β cells. GLM is a human IgG1κ monoclonal antibody specific for tumor necrosis factor α. This study assessed whether GLM preserves β-cell function in children and young a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::187ead4a9d7f5a1c24765972312931dc
https://doi.org/10.2337/db20-3-lb

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání